During the past decade, Minnesota Lung Center conducted 26 clinical trials. In the 10-year time frame, 26 clinical trials started and 18 clinical trials were completed, i.e. on average, 69.2% percent of trials that started reached the finish line to date. In the past 5 years, 13 clinical trials started and 11 clinical trials were completed. i.e. 84.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Minnesota Lung Center" #1 sponsor was "Boehringer Ingelheim" with 7 trials, followed by "Jazz Pharmaceuticals" with 6 trials sponsored, "Sunovion Respiratory Development Inc." with 4 trials sponsored, "Bellus Health Inc" with 2 trials sponsored and "Harmony Biosciences, LLC" with 2 trials sponsored. Other sponsors include 6 different institutions and companies that sponsored additional 16 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Minnesota Lung Center" #1 collaborator was "Inogen Inc." with 1 trials as a collaborator and "Iqvia Pty Ltd" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Minnesota Lung Center" are "COPD" (6 trials), "Idiopathic Pulmonary Fibrosis" (6 trials), "Narcolepsy" (4 trials), "Chronic Obstructive Pulmonary Disease" (3 trials) and "Idiopathic Hypersomnia" (3 trials). Many other conditions were trialed in "Minnesota Lung Center" in a lesser frequency.

Most popular intervention types in "Minnesota Lung Center" are "Drug" (28 trials), "Device" (3 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (10 trials), "JZP-110" (3 trials), "Nintedanib" (3 trials), "Placebo oral tablet" (3 trials) and "SUN-101 50 mcg BID eFlow (CS) nebulizer" (3 trials). Other intervention names were less common.

The vast majority of trials in "Minnesota Lung Center" are 32 trials for "All" genders.

Currently, there are NaN active trials in "Minnesota Lung Center". undefined are not yet recruiting, 5 are recruiting, 1 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 23 completed trials in Minnesota Lung Center, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Minnesota Lung Center, 0 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 17 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 3 trials that are defined as “Not Applicable".